强力霉素
水溶液
自愈水凝胶
傅里叶变换红外光谱
化学
差向异构体
聚合物
核化学
色谱法
材料科学
化学工程
高分子化学
有机化学
生物化学
工程类
抗生素
作者
Venu Gopal Reddy Patlolla,W. Peter Holbrook,Sveinbjörn Gizurarson,T. Kristmundsdóttir
标识
DOI:10.2174/1570163816666190222193902
摘要
Background: The main aim of this work was to develop stable (>2 years) doxycycline formulation, at clinically relevant concentrations and using clinically relevant formulation. Doxycycline has a MMP- inhibitory effects that is important for the treatment of various oral mucosal conditions. Therefore, protecting doxycycline from degradation in aqueous formulation requires halting or prevention of oxidation and epimerisation of the active compound. Methods: Stabilizing excipients were intuitively put together to enhance the stability as a cumulative effort. A total of 30 hydrogels were compared with different types and concentrations of stability enhancing excipients, pH, storage temperatures (4, 25 and 40°C) and mucoadhesive polymers. The duration of the study was from day 1 and up to 58 months. The gelation temperature was adjusted below the actual body temperature. The complexation efficiency between the doxycycline and HPβCD was studied using the DSC, FTIR and XRPD. Results: The majority of formulations at 4°C were highly stable by the end of 58 months and their stabilities were improved at all 3 temperatures. Conclusion: In conclusion, it is possible to prevent doxycycline from both oxidation and epimerization in an aqueous formulation, for up to 5 years.
科研通智能强力驱动
Strongly Powered by AbleSci AI